Back
MoonLake Immunotherapeutics Stock Predictions
Free Access to "King of the Quants" Stock Rating System
[Claim Your 3 Free Grades Now]
Sell
15
MLTX
MoonLake Immunotherapeutics
Last Price:
$43.94
Seasonality Move:
-5.84%
7 Day Trial
ALL ACCESS PASS
$
7
Access "King of the Quants" Stock Rating System FREE!
[Claim Your 3 Free Grades Now]MoonLake Immunotherapeutics Stock Forecast
-
Over the next 52 weeks, MoonLake Immunotherapeutics has on average historically risen by 93.5% based on the past 4 years of stock performance.
-
MoonLake Immunotherapeutics has risen higher in 2 of those 4 years over the subsequent 52-week period, corresponding to a historical accuracy of 50%
-
Is MoonLake Immunotherapeutics Stock Undervalued?The current MoonLake Immunotherapeutics [MLTX] share price is $43.81. The Score for MLTX is 15, which is 70% below its historic median score of 50, and infers higher risk than normal.
-
MLTX is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
Will MoonLake Immunotherapeutics Stock Go Up Next Year?
-
Over the next 52 weeks, MoonLake Immunotherapeutics has on average historically risen by 93.5% based on the past 4 years of stock performance.
MoonLake Immunotherapeutics Stock Rating
Sell
15
MoonLake Immunotherapeutics (MLTX)
is a Sell
Is MoonLake Immunotherapeutics overpriced?
-
MoonLake Immunotherapeutics has risen higher in 2 of those 4 years over the subsequent 52-week period, corresponding to a historical accuracy of 50%
MoonLake Immunotherapeutics Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
Switzerland
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
moonlaketx.com
52-Week Data
52-Week High:
64.98
52-Week Low:
37.55
Prediction Charts
Market Cap:
2.8B
Price in USD:
43.81
Volume:
807.6K
Beta:
1.32
Technical Analysis
SMA50:
51.48
SMA100:
50.29
SMA200:
46.82
52-Wk Change:
-22.34%
Stock Predictions
-
Is MoonLake Immunotherapeutics stock public?Yes, MoonLake Immunotherapeutics is a publicly traded company.
-
What is the MoonLake Immunotherapeutics stock quote today?The MoonLake Immunotherapeutics stock price is 43.81 USD today.
-
How to buy MoonLake Immunotherapeutics stock online?You can buy MoonLake Immunotherapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Dec-27 | 54.44 | 55.37 | 55.68 | 53.79 |
| Dec-30 | 54.60 | 53.02 | 55.50 | 52.50 |
| Dec-31 | 53.75 | 54.15 | 55.46 | 53.14 |
| Jan-2 | 54.21 | 53.57 | 56.00 | 53.44 |
| Jan-3 | 53.56 | 53.45 | 55.01 | 53.02 |
| Jan-6 | 53.43 | 51.75 | 53.66 | 50.79 |
| Jan-7 | 51.59 | 50.21 | 52.80 | 50.00 |
| Jan-8 | 50.50 | 48.17 | 50.50 | 48.00 |
| Jan-10 | 48.00 | 46.32 | 48.87 | 46.00 |
| Jan-13 | 46.00 | 45.26 | 46.48 | 43.64 |
| Jan-14 | 46.09 | 46.50 | 46.92 | 44.23 |
| Jan-15 | 47.46 | 43.97 | 49.06 | 43.50 |
| Jan-16 | 44.25 | 41.47 | 44.97 | 41.27 |
| Jan-17 | 44.83 | 43.81 | 44.90 | 41.92 |
MoonLake Immunotherapeutics Earnings
MoonLake Immunotherapeutics Earnings Report: Per Share MoonLake Immunotherapeutics Earnings Q1 Q2 Q3 and Q4 last year and next year.
MoonLake Immunotherapeutics Forecast Revenue Growth
MoonLake Immunotherapeutics Stock Analysis: Historical quarterly revenues per share for MoonLake Immunotherapeutics and historical quarterly revenue growth:
-
Analysts estimate an earnings decrease this quarter of $0.28 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.75 per share, and a decrease next year of $0.83 per share.
* MoonLake Immunotherapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.